Advertisement
Canada markets closed
  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CAD/USD

    0.7300
    +0.0002 (+0.03%)
     
  • CRUDE OIL

    82.77
    -0.04 (-0.05%)
     
  • Bitcoin CAD

    88,422.92
    -3,055.41 (-3.34%)
     
  • CMC Crypto 200

    1,395.74
    -28.36 (-1.99%)
     
  • GOLD FUTURES

    2,330.10
    -8.30 (-0.35%)
     
  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     
  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     
  • NASDAQ futures

    17,487.25
    -177.25 (-1.00%)
     
  • VOLATILITY

    15.97
    +0.28 (+1.78%)
     
  • FTSE

    8,040.38
    -4.43 (-0.06%)
     
  • NIKKEI 225

    38,003.54
    -456.54 (-1.19%)
     
  • CAD/EUR

    0.6818
    -0.0001 (-0.01%)
     

Analysts’ Recommendations for Biogen in 1Q17

Biogen (BIIB) currently holds a 38.0% share of the global MS market. In 1Q17, the company reported revenues of around $2.2 billion for its MS franchise